Li X, He Y, Wang Z, Wei J, Hu T, Si J, et al. A combination therapy of phages and antibiotics: two is better than one. Int J Biol Sci. 2021;17:3573–82.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Namivandi-Zangeneh R, Wong EHH, Boyer C. Synthetic antimicrobial polymers in combination therapy: tackling antibiotic resistance. ACS Infect Dis. 2021;7:215–53.

Article  CAS  PubMed  Google Scholar 

Shaw E, Wuest WM. Virulence attenuating combination therapy: a potential multi-target synergy approach to treat Pseudomonas aeruginosa infections in cystic fibrosis patients. RSC Med Chem. 2020;11:358–69.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cheng Y-S, Williamson PR, Zheng W. Improving therapy of severe infections through drug repurposing of synergistic combinations. Curr Opin Pharm. 2019;48:92–8.

Article  CAS  Google Scholar 

Möhler JS, Sim W, Blaskovich MAT, Cooper MA, Ziora ZM. Silver bullets: a new lustre on an old antimicrobial agent. Biotechnol Adv. 2018;36:1391–411.

Article  PubMed  Google Scholar 

Ni W, Shao X, Di X, Cui J, Wang R, Liu Y. In vitro synergy of polymyxins with other antibiotics for Acinetobacter baumannii: a systematic review and meta-analysis. Int J Antimicrob Agents. 2015;45:8–18.

Article  CAS  PubMed  Google Scholar 

Yap PSX, Yiap BC, Ping HC, Lim SHE. Essential Oils, a new horizon in combating bacterial antibiotic resistance. Open Microbiol J. 2014;8:6–14.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jackson J, Chen C, Buising K. Aminoglycosides. Curr Opin Infect Dis. 2013;26:516–25.

Article  CAS  PubMed  Google Scholar 

Liu Y, Li H, Zhang Y, Ye Y, Gao Y, Li J. In vitro and in vivo activity of ciprofloxacin/fosfomycin combination therapy against ciprofloxacin-resistant Shigella flexneri isolates. Infect Drug Resist. 2019;12:1619–28.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kim SE, Kim HK, Choi S-M, Yu Y, Kim UJ, Darboe KS, et al. In vitro synergy and in vivo activity of tigecycline-ciprofloxacin combination therapy against vibrio vulnificus sepsis. Antimicrob Agents Chemother. 2019;63. https://doi.org/10.1128/AAC.00310-19.

Elkhatib W, Noreddin A. Efficacy of ciprofloxacin-clarithromycin combination against drug-resistant pseudomonas aeruginosa mature biofilm using in vitro experimental model. Microb Drug Resistance. 2014;20:575–82.

Article  CAS  Google Scholar 

Siqueira VLD, Cardoso RF, Caleffi-Ferracioli KR, de Lima Scodro RB, Fernandez MA, Fiorini A, et al. Structural changes and differentially expressed genes in pseudomonas aeruginosa exposed to meropenem-ciprofloxacin combination. Antimicrob Agents Chemother. 2014;58:3957–67.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jang H-C, Choi S-M, Kim HK, Kim S-E, Kang S-J, Park K-H, et al. In vivo efficacy of the combination of ciprofloxacin and cefotaxime against vibrio vulnificus sepsis. PLoS One. 2014;9:e101118.

Article  PubMed  PubMed Central  Google Scholar 

Chang C-M, Lee H-C, Lee N-Y, Huang G-C, Lee I-W, Ko W-C. Cefotaxime-ciprofloxacin combination therapy for nontyphoid salmonella bacteremia and paravertebral abscess after failure of monotherapy. Pharmacotherapy. 2006;26:1671–4.

Article  PubMed  Google Scholar 

Beach JM, Champney WS. An examination of the inhibitory effects of three antibiotics in combination on ribosome biosynthesis in Staphylococcus aureus. Arch Microbiol. 2014;196:249–60.

Article  CAS  PubMed  Google Scholar 

Drago L, de Vecchi E, Nicola L, Legnani D, Lombardi A, Gismondo MR. In vitro synergy and selection of resistance by fluoroquinolones plus amikacin or β-lactams against extended-spectrum β-lactamase-producing Escherichia coli. J Chemother. 2005;17:46–53.

Article  CAS  PubMed  Google Scholar 

Brouqui P, Rousseau MC, Stein A, Drancourt M, Raoult D. Treatment of Pseudomonas aeruginosa-infected orthopedic prostheses with ceftazidime-ciprofloxacin antibiotic combination. Antimicrob Agents Chemother. 1995;39:2423–5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dey R, Sultana S, Bishayi B. Combination treatment of celecoxib and ciprofloxacin attenuates live S. aureus induced oxidative damage and inflammation in murine microglia via regulation of cytokine balance. J Neuroimmunol. 2018;316:23–39.

Article  CAS  PubMed  Google Scholar 

Cho D-Y, Lim DJ, Mackey C, Skinner D, Zhang S, McCormick J, et al. Ivacaftor, a cystic fibrosis transmembrane conductance regulator potentiator, enhances ciprofloxacin activity against Pseudomonas aeruginosa. Am J Rhinol Allergy. 2019;33:129–36.

Article  PubMed  Google Scholar 

Soboh F, Khoury AE, Zamboni AC, Davidson D, Mittelman MW. Effects of ciprofloxacin and protamine sulfate combinations against catheter-associated Pseudomonas aeruginosa biofilms. Antimicrob Agents Chemother. 1995;39:1281–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lu Q, Yu J, Bao L, Ran T, Zhong H. Effects of combined treatment with ambroxol and ciprofloxacin on catheter-associated pseudomonas aeruginosa biofilms in a rat model. Chemotherapy. 2013;59:51–6.

Article  CAS  PubMed  Google Scholar 

Kart D, Reçber T, Nemutlu E, Sagiroglu M. Sub-inhibitory concentrations of ciprofloxacin alone and combinations with plant-derived compounds against P. aeruginosa Biofilms and their effects on the metabolomic profile of P. aeruginosa Biofilms. Antibiotics. 2021;10:414.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lin Y, Quan D, Chang RYK, Chow MYT, Wang Y, Li M, et al. Synergistic activity of phage PEV20-ciprofloxacin combination powder formulation—A proof-of-principle study in a P. aeruginosa lung infection model. Eur J Pharm Biopharm. 2021;158:166–71.

Article  CAS  PubMed  Google Scholar 

Mohamed SH, Mohamed MSM, Khalil MS, Azmy M, Mabrouk MI. Combination of essential oil and ciprofloxacin to inhibit/eradicate biofilms in multidrug-resistant Klebsiella pneumoniae. J Appl Microbiol. 2018;125:84–95.

Article  CAS  PubMed  Google Scholar 

Zhou X-Y, Ye X-G, He L-T, Zhang S-R, Wang R-L, Zhou J, et al. In vitro characterization and inhibition of the interaction between ciprofloxacin and berberine against multidrug-resistant Klebsiella pneumonia e. J Antibiot (Tokyo). 2016;69:741–6.

Article  CAS  PubMed  Google Scholar 

Chan BCL, Ip M, Lau CBS, Lui SL, Jolivalt C, Ganem-Elbaz C, et al. Synergistic effects of baicalein with ciprofloxacin against NorA over-expressed methicillin-resistant Staphylococcus aureus (MRSA) and inhibition of MRSA pyruvate kinase. J Ethnopharmacol. 2011;137:767–73.

Article  CAS  PubMed  Google Scholar 

Dey D, Debnath S, Hazra S, Ghosh S, Ray R, Hazra B. Pomegranate pericarp extract enhances the antibacterial activity of ciprofloxacin against extended-spectrum β-lactamase (ESBL) and metallo-β-lactamase (MBL) producing Gram-negative bacilli. Food Chem Toxicol. 2012;50:4302–9.

Article  CAS  PubMed  Google Scholar 

Arora S, Baptista C, Lim CS. Maggot metabolites and their combinatory effects with antibiotic on Staphylococcus aureus. Ann Clin Microbiol Antimicrob. 2011;10:6.

Article  PubMed  PubMed Central  Google Scholar 

Tambat R, Jangra M, Mahey N, Chandal N, Kaur M, Chaudhary S, et al. Microbe-derived indole metabolite demonstrates potent multidrug efflux pump inhibition in staphylococcus aureus. Front Microbiol. 2019;10. https://doi.org/10.3389/fmicb.2019.02153.

Genilloud O. Mining actinomycetes for novel antibiotics in the omics era: are we ready to exploit this new paradigm? Antibiotics. 2018;7:85.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nampoothiri KM, Ramkumar B, Pandey A. Western ghats of india: rich source of microbial biodiversity. J Sci Ind Res (India). 2013;72:617–23.

Google Scholar 

Vasava ZT, Mistry KJ, Patel PP, Markande AR. Exploring microbial bioactive molecules from Western Ghats, India. Acta Ecologica Sinica. 2021. https://doi.org/10.1016/j.chnaes.2021.09.011.

Drissya T, Induja DK, Poornima MS, Jesmina ARS, Prabha B, Saumini M, et al. A novel aureothin diepoxide derivative from Streptomyces sp. NIIST-D31 strain. J Antibiot (Tokyo). 2022. https://doi.org/10.1038/s41429-022-00547-1.

CLSI. Performance standards for antimicrobial disk susceptibility tests; approved standard- Eleventh edition. CLSI document M02-A11 29. 2012;1–54.

Fadwa AO, Alkoblan DK, Mateen A, Albarag AM. Synergistic effects of zinc oxide nanoparticles and various antibiotics combination against pseudomonas aeruginosa clinically isolated bacterial strains. Saudi J Biol Sci. 2021;28:928–35.

Article  CAS  PubMed  Google Scholar 

Kumar SN, Lankalapalli RS, Kumar BSD. In vitro antibacterial screening of six proline-based cyclic dipeptides in combination with β-lactam antibiotics against medically important bacteria. Appl Biochem Biotechnol. 2014;173:116–28.

Article  CAS  PubMed  Google Scholar 

Mal A, Vijayakumar S, Mishra RK, Jacob J, Pillai RS, Dileep Kumar BS, et al. Supramolecular surface charge regulation in ionic covalent organic nanosheets: reversible exfoliation and controlled bacterial growth. Angew Chem - Int Ed. 2020;59:8713–9.

Article  CAS  Google Scholar 

Jacob J, Rajendran RU, Priya SH, Purushothaman J, Saraswathy Amma DKBN. Enhanced antibacterial metabolite production through the application of statistical methodologies by a Streptomyces nogalater NIIST A30 isolated from Western Ghats forest soil. PLoS One. 2017;12:1–21.

Article  Google Scholar 

Bauer AW, Kirby WM, Sherris JC, Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol. 1966;45:493–6.

Article  CAS  PubMed  Google Scholar 

Anupama N, Preetha Rani MR, Shyni GL, Raghu KG. Glucotoxicity results in apoptosis in H9c2 cells via alte